Evaluation of the Effectiveness of Montelukast in Children With Recurrent Obstructive Bronchitis

• Status: Active, not recruiting
• Trial end date: 2024-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study was to evaluate the effectiveness of montelukast sodium in the treatment and prevention of recurrent obstructive bronchitis in children. The investigators examined 80 children aged 1 to 7 years with recurrent obstructive bronchitis, who were randomly divided into 2 groups.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Samarkand State Medical Institute
• Treatments: Montelukast

Criteria

Inclusion Criteria:

• RDA score=6 points

• E:I index score >1.40

• ineffective treatment at home for ≥48 hours

• adverse comorbidities

Exclusion Criteria:

• chronic or congenital diseases of the Central nervous, cardiovascular and bronchopulmonary systems